期刊
BULLETIN OF THE KOREAN CHEMICAL SOCIETY
卷 42, 期 11, 页码 1419-1429出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/bkcs.12390
关键词
Alzheimer's disease; Amyloid degrading enzyme; Matrix metalloproteinase; Neprilysin
资金
- National Research Foundation of Korea (NRF) - Korea government (MSIT) [2020R1G1A1003993]
- National Research Foundation of Korea [2020R1G1A1003993] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
Dementia, especially Alzheimer's disease, has become a common disease in an aging society. Clearing toxic Aβ species from the brain by regulating the activity of amyloid degrading enzymes could be an effective treatment for AD.
In an aging society in the world, dementia that leads to pain in patients and their families has become a common disease in our lives. Among dementia, Alzheimer's disease (AD) is the most commonly shown disease. Various causes of the disease have been proposed and amyloid hypothesis insists that the toxic amyloid-beta (A beta) species could be the major risk factor of the onset and progression of AD. In this perspective, clearance of A beta species from the brain by regulating the activity of amyloid degrading enzymes (ADE), including neprilysin and matrix metalloproteinases, could be a potent treatment for AD. Therefore, the structures and functions of these enzymes along with biological molecules in the brain would be important to understand the pathogenesis of AD and develop an effective medication for the disease. In this review, multiple ADE with biological molecules which could affect the activities and/or expression of the enzymes are summarized.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据